about
Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic MedicineIdentification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP databaseNeuroimaging-based biomarkers for treatment selection in major depressive disorder.Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.Tumour location within the breast: Does tumour site have prognostic ability?Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targetsTreatment Choices Based on OncotypeDx in the Breast Oncology Care Setting.Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items.Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Single-nucleotide polymorphisms in PSCA and the risk of breast cancer in a Chinese population.Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelinesGenomic Disparities in Breast Cancer Among Latinas.Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates.Genetic factors associated with age-related macular degeneration.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients.Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population.Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications.The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care.A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.Mammalian sterile 20-like kinase 1 expression and its prognostic significance in patients with breast cancer.Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.Estimating optimal treatment regimes via subgroup identification in randomized control trials and observational studies.Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.PHLDA1 (pleckstrin homology-like domain, family A, member 1) knockdown promotes migration and invasion of MCF10A breast epithelial cells.Analysis of novel mutations in BRCA1 in Iranian families with breast cancer.Gene signatures of genomic instability as prognostic tools for breast cancer.Estimating individualized treatment rules for ordinal treatments.Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity.
P2860
Q26740365-D951FD0D-8754-49F6-818D-3BBE52499C91Q30000832-C190C8C8-928C-4C16-BD86-6F453DF7738BQ30903129-B7E25C17-13F6-471C-9341-DD2266F4E11BQ34204882-22A6800E-4510-4ACE-A8FE-AE33270B57B1Q35836700-6717BED3-B5D5-4530-9BCF-209C4C24BD3BQ35935349-72F78F5D-0B46-4E12-8F93-0A1CD8F5ABE1Q35952040-6CE1B803-8B18-4128-BB00-DD1BD8B995F9Q36183761-376181C7-88E5-46C5-82A4-70E22BC89FB9Q36567487-B6515953-9C22-4DD9-8196-8348F3F3E68AQ36618624-F422B0A2-DE1C-4FAD-A57F-F11EBFE8A16EQ37317360-92BB305C-1942-4964-868A-82F2E350D024Q37492422-2F521261-3F1D-4A54-A283-2BC813F2A180Q37509093-449627A6-83DC-400E-9D48-C7104DABB36EQ37731513-6739E946-3077-4564-B865-FEAA24A926FAQ37901276-D953BA6D-3993-4827-8AE1-DD49A379C40AQ38983589-A473DA2E-2631-48EA-95CD-8401F3C79A1EQ41843765-FA6CA497-EB12-435F-9D74-3891114D84B2Q45120607-16E08276-E448-4C03-BBA8-77574C647AE3Q45331759-5C945258-C849-48E4-9D7C-73D6561AFE31Q46033349-0C78B671-7550-4A42-A763-659D5A453104Q46258028-061332CC-A3B0-4AB1-A768-4613BC34EB78Q47147401-EE851B53-5536-4DB4-9B13-0391BB7CFACEQ47204651-A2657D24-2688-42BD-BF5A-ADC029506D9CQ47449122-B6A7D2A1-2A8E-46D8-A038-2D2C84198718Q47949053-E253FDE1-0FD6-40EE-A2C7-98218BC56F00Q48225335-285B8706-A5C6-4B77-9116-96946582A5A6Q48236257-1EFF5091-554E-46B2-8513-1789A8895434Q51126568-1EFE9F5F-83F5-42A4-9904-9404E1A908B9Q51708775-FDFC7B62-83EB-4415-97D9-731CF8DCCE6BQ52657886-F91B1E62-62EF-4EC1-B822-34C1D5801A07Q55257994-3C77BCED-D6F2-4A34-A9A8-24B701C14B37
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Breast cancer in the personal genomics era
@ast
Breast cancer in the personal genomics era
@en
Breast cancer in the personal genomics era
@nl
type
label
Breast cancer in the personal genomics era
@ast
Breast cancer in the personal genomics era
@en
Breast cancer in the personal genomics era
@nl
prefLabel
Breast cancer in the personal genomics era
@ast
Breast cancer in the personal genomics era
@en
Breast cancer in the personal genomics era
@nl
P2093
P2860
P3181
P1433
P1476
Breast cancer in the personal genomics era
@en
P2093
Craig D Shriver
Darrell L Ellsworth
David J Decewicz
Rachel E Ellsworth
P2860
P304
P3181
P356
10.2174/138920210791110951
P407
P577
2010-05-01T00:00:00Z